David C. Smith
University of Michigan(US)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Bladder and Urothelial Cancer Treatments, Cancer Treatment and Pharmacology, Cancer Immunotherapy and Biomarkers, Urinary and Genital Oncology Studies
Most-Cited Works
- → Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer(2012)12,531 cited
- → Integrative Clinical Genomics of Advanced Prostate Cancer(2015)3,599 cited
- → Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial(2016)2,785 cited
- → Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab(2014)2,198 cited
- → Overall Survival and Long-Term Safety of Nivolumab (Anti–Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer(2015)1,189 cited
- → Integrative clinical genomics of metastatic cancer(2017)918 cited